By Nigam Arora & Dr. Natasha Arora
Signal(s) to enter, add, reduce, exit, hold or change.
Microsoft (MSFT) is in the first inning of its major AI opportunity. A fortune is to be made in AI over the next seven years. MSFT should be the cornerstone of profiting from AI. However, it is very important to systematically accumulate MSFT stock when it falls in the buy zone, if you do not already own it.
Core Model Portfolio
MSFT stock is in the core Model Portfolio of ZYX Buy by The Arora Report. Most long time members of The Arora Report have already built a large position in MSFT and are now profiting from the run up.
Earnings
Microsoft earnings were better than the consensus and whisper numbers. Stocks move up when the reported earnings and projections are better than the whisper numbers. Whisper numbers are the numbers that analysts do not publish but share privately only with their best clients.
Here are the key points from the earnings:
- Microsoft cloud known as Azure grew by 29% vs. 26% consensus.
- The growth is primarily due to demand for the AI tech stack.
- Microsoft’s GitHub Copilot is growing rapidly. It now has over 1M paid users.
- Microsoft is keeping tight control on its expenses.
- Microsoft’s acquisition of Activision will add to its strength in video gaming.
Zones
For those who are following the Good Way, the Buy Now rating is *** (To see the locked content, please take a 30 day free trial).
For those following the Best Way, the buy zone is ***.
The recommended quantity is 55% – 80%.
The very long term target is $482 – $506.
The Best Two Of The Magnificent Seven
The magnificent seven stocks are Apple (AAPL), Amazon (AMZN), Alphabet (GOOG, GOOGL), Meta (META), Microsoft (MSFT), Nvidia (NVDA), and Tesla (TSLA).
For artificial intelligence, the best two of the magnificent seven stocks at this time are Microsoft and Nvidia. Keep in mind that in the world of investments, nothing is cast in stone. Markets are dynamic. For this reason, it is important for investors to stay in tune with the Real Time Feed by The Arora Report.
18 Artificial Intelligence Stocks
The world is going through a revolution that will change the way we live, work, and invest. We are now in the golden age of artificial intelligence (AI), where the possibilities for growth and innovation are endless. The power of AI is already transforming the world we live in. AI is driving the development of self-driving cars, revolutionizing healthcare, improving productivity in businesses, and changing the way we interact with technology.
In The Arora Report analysis, AI is a $5 trillion market. To take advantage of the opportunity, there are 18 artificial intelligence stocks that investors should watch. Please click here for the list.
What To Do Now
Those in the stock may consider continuing to hold. Those not in the stock may consider following the parameters given above.
To take a free 30-day trial to paid services to gain access to more opportunities, please click here.
This post was just published on ZYX Buy Change Alert.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE
TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
